Active

OncoRNA

Switched

BE0805162158

Rechtspersoon Public limited company 1 establishment

Rue Louis Breguet 1, 6041 Charleroi Speur- en ontwikkelingswerk op biotechnologisch gebied

Active for

3 year

Financials

Financial year 2025

Worth noting

  • More debts than assets in the latest financial year.
  • A loss two years in a row.
  • Little cash and receivables against the short-term debts.

Gross margin

€ -15,237

▲ 58% vs 2024

Profit

Caution

€ -15,560

▲ 59% vs 2024

Debts

High

€ 51,880

▲ 58% vs 2024

OncoRNA from Charleroi, company number BE0805162158, closed financial year 2025 with a result of € -15,560 after tax. For that financial year OncoRNA recorded a gross margin of € -15,237 and equity of € -31,846. Compared with financial year 2024, the result moved from € -38,269 to € -15,560. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 14, 2026.

What happened at OncoRNA?

What happened at OncoRNA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • ONCODNA SA stepped down as director. NBB
  • François BLONDEL stepped down as director. NBB
  • Christophe VAN HUFFEL stepped down as director. NBB
  • Jean-Pol DETIFFE stepped down as director. NBB
  • New annual accounts for financial year 2025: loss of € 15,560. Source: NBB ↗
  • New establishment in Charleroi. KBO
  • ONCODNA SA became a director. NBB
  • François BLONDEL became a director. NBB

In short

From € 39,517 loss in 2023 to € 15,560 loss in 2025.

A new publication or filing at OncoRNA? We notify you, reason included.

Follow OncoRNA

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New
Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Directors

According to the 2025 annual accounts

ONCODNA SA

Director · represented by Charles-André BROUWERS

since 2023 · until 2029

François BLONDEL

Director

since 2023 · until 2029

Christophe VAN HUFFEL

Director

Also active at: GENERGON

since 2023 · until 2029

since 2023 · until 2029

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Louis Breguet 1

6041 Charleroi

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

Details

Company number
0805.162.158
VAT number
BE 0805.162.158
Registered office
Rue Louis Breguet 1, 6041 Charleroi
Names & denominations
OncoRNA
Enterprise type
Rechtspersoon
Legal form
Public limited company
Legal situation
Normale toestand
Start date
28 August 2023
Peppol
Active · Active since 25 Nov 2025
Activities · NACE

Speur- en ontwikkelingswerk op biotechnologisch gebied

Vervaardiging van overige farmaceutische producten

Vervaardiging van geneesmiddelen

Frequently asked questions

What is the enterprise number of OncoRNA?
The enterprise number of OncoRNA is BE0805162158.
What is the address of OncoRNA?
The registered office of OncoRNA is located at Rue Louis Breguet 1, 6041 Charleroi.
When was OncoRNA founded?
OncoRNA was founded on 28 August 2023.
What is the main activity of OncoRNA?
The main activity of OncoRNA is "Speur- en ontwikkelingswerk op biotechnologisch gebied" (NACE code 72101).
Does OncoRNA have a website?
No website is currently known for OncoRNA.
How much profit did OncoRNA make in 2025?
OncoRNA recorded a loss after taxes of € 15,560 in financial year 2025.
What is the revenue of OncoRNA?
As a small company, OncoRNA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -15,237.
Where can I find the annual accounts of OncoRNA?
OncoRNA files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.
Who are the directors of OncoRNA?
According to the 2025 annual accounts, the directors of OncoRNA are: ONCODNA SA, François BLONDEL, Christophe VAN HUFFEL, Jean-Pol DETIFFE.